Larger clinical trial sizes, rising cost of patient recruitment and retention, and the increasing complexity and number of procedures are key reasons why drug development costs have grown exponentially. With the 20-year patent clock ticking from the time the Investigational New Drug Application (INDA) is submitted, over half of the patent-protected life is consumed in developing, testing, and seeking FDA approval. Shortening the time required to get one drug to the market can lead to an enormous difference in the revenue a drug will generate. Drug development time and the costs required to develop a drug can be reduced most effectively by employing the many technological innovations available today to organize and expedite the drug development processes. The clinical trials area in particular is poised to adopt new technology, and eliminate the heavily inefficient manual processes. Xyntek’s expertise incorporating today’s latest technologies to automate processes in the medical, biopharmaceutical, and manufacturing industries equip us to automate the needs of the clinical trial processes quickly and effectively. Xyntek uses technology to facilitate capturing, analyzing, and sharing clinical trial data, meeting FDA regulations, and marketing the final approved product. |